Cognoa Revenue and Competitors

Location

#1961

Growjo Ranking

Estimated Revenue & Valuation

  • Cognoa's estimated annual revenue is currently $9M per year.(i)
  • Cognoa received $11.6M in venture funding in March 2017.
  • Cognoa's estimated revenue per employee is $121,800
  • Cognoa's total funding is $20M.

Employee Data

  • Cognoa has 74 Employees.(i)
  • Cognoa grew their employee count by 3% last year.

Cognoa's People

NameTitleEmail/Phone
1
Chief People OfficerReveal Email/Phone
2
Sr. VP, FinanceReveal Email/Phone
3
CEOReveal Email/Phone
4
VP, Market AccessReveal Email/Phone
5
SVP, CommercialReveal Email/Phone
6
VP EngineeringReveal Email/Phone
7
Director Product Management and OperationReveal Email/Phone
8
Executive Medical DirectorReveal Email/Phone
9
Senior Medical Director Clinical AdoptionReveal Email/Phone
10
Director Access&Strategic PartnershipsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$212.8M10635%$65MN/A
#2
$35.6M2316%N/AN/A
#3
$45M299-4%$102.6MN/A
#4
$3.2M30-25%$21.3MN/A
#5
$34M2260%$42.9MN/A
#6
$3.6M34-28%$35MN/A
#7
$0.8M10N/AN/AN/A
#8
$12.6M90-9%N/AN/A
#9
$17.4M1240%$96.4MN/A
#10
$5.2M49-25%$75.6MN/A
Add Company

What Is Cognoa?

Cognoa's mission is to give every child the chance for healthy development. Our clinically-validated developmental assessment, built upon proprietary machine learning algorithms originally developed at Harvard Medical School, tells parents their child's risk for developmental delay and autism. We also help all children reach developmental milestones and improve in areas of parental concern. Cognoa is available to parents via their employers, and we have already served 250,000 families.

keywords:Biotechnology,Education,Healthcare,Human Resources Hr,Medical Diagnostics,Mobile,Pharmaceuticals

$20M

Total Funding

74

Number of Employees

$9M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cognoa News

2022-04-20 - Autism Acceptance Month – Using AI to improve early diagnosis

Canvas Dx, developed by Cognoa, uses artificial intelligence (AI) to process three inputs: a brief caregiver questionnaire, a questionnaire...

2022-04-17 - Why An Autism Diagnosis Is Not A Label But A Roadmap

Colleen Kraft, former AAP President and Senior Medical Director of Clinical Adoption at Cognoa, a leading digital behavioral health company,...

2022-03-22 - Cognoa named one of Fierce Medtech's "Fierce 15 ...

Cognoa is a pediatric behavioral health company developing digital diagnostic and therapeutic products with the goals of enabling earlier and...

2021-09-30 - Cognoa : Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer

PALO ALTO, Calif., Sept. 30, 2021 /PRNewswire/ -- Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health conditions, today announced that Tony Rimac has joined as Chief Financial Officer (CFO). Rimac joins Cognoa's ...

2019-10-25 - Cognoa Launches Pivotal Study of Diagnostic Aid for Autism

– Cognoa launches a pivotal study to demonstrate the effectiveness of its diagnostic aid for autism spectrum disorder (ASD). – The results of this pivotal study will be the basis for the submission to the FDA in 2020. – The Cognoa digital diagnostic aid has the potential to become the first cl ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M74-3%$16.7M
#2
$10.7M7416%N/A
#3
$9.7M7421%N/A
#4
$20M74-17%N/A
#5
$9.8M753%N/A

Cognoa Funding

DateAmountRoundLead InvestorsReference
2017-03-29$11.6MUndisclosedMorningsideArticle